Cardinal Health, Inc.
CAH (NYSE)
Cardinal Health, Inc. stands out as a solid investment option, boasting a remarkable 51.47% return over the past year and an impressive 231.39% over five years, indicating strong growth potential. With a dividend yield of nearly 1%, the company has consistently delivered dividends for 29 years, showcasing its commitment to reliable income for investors. Analysts maintain a consensus Buy rating, with a median price target of $256, reflecting confidence in its distribution and supply chain strengths.
Pros:
- Strong distribution and supply chain strengths
- High demand for specialized pharmaceutical distribution
Cons:
- Recent minor short-term dip
- Market competition
Cardinal Health, Inc. (CAH) may be suitable for investors seeking exposure to a stable company with a strong track record of growth and consistent dividend payments. Its solid returns over both one and five years, coupled with a moderate dividend yield, suggest it could appeal to those looking for a blend of capital appreciation and income stability in the healthcare sector.